Are You Compliant With Addressing Glaucoma Adherence?

American Journal of Ophthalmology

Volumn 149, Issue 1, 2010, Pages 1-3

  Mansberger, Steven L ^a  

^a DEVERS EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; EYE DROPS;

ACCURACY; BLINDNESS; CATARACT EXTRACTION; DISEASE COURSE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG COST; DRUG MONITORING; EDITORIAL; EYE CARE; GLAUCOMA; HEALTH BEHAVIOR; HEALTH BELIEF MODEL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACY; PRIORITY JOURNAL; PRODUCTIVITY; TRAVEL; VISUAL IMPAIRMENT;

ANTIHYPERTENSIVE AGENTS; COST OF ILLNESS; GLAUCOMA; HUMANS; MEDICATION ADHERENCE; PATIENT COMPLIANCE; PATIENTS;

EID: 72049122908     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.08.011     Document Type: Editorial

References (14)

1. Friedman D.S., Nordstrom B., Mozaffari E., and Quigley H.A. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology 112 (2005) 1500-1504
2. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-830
3. Leske M.C., Heijl A., Hyman L., and Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106 (1999) 2144-2153
4. Okeke C.O., Quigley H.A., Jampel H.D., et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid Study. Ophthalmology 116 (2009) 191-199
5. Nordstrom B.L., Friedman D.S., Mozaffari E., Quigley H.A., and Walker A.M. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140 (2005) 598-606
6. Rogers P.G., and Bullman W.R. Prescription medicine compliance: A review of the baseline of knowledge. A report of the National Council on Patient Information and Education. J Pharmacoepidemiology 3 (1996) 3-36
7. Rein D.B., Zhang P., Wirth K.E., et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 124 (2006) 1754-1760
8. Herman D.C., Gordon M.O., Beiser J.A., et al. Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol 142 (2006) 800-810
9. Kass M.A., Gordon M., and Meltzer D.W. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?. Am J Ophthalmol 101 (1986) 524-530
10. Kass M.A., Meltzer D.W., Gordon M., Cooper D., and Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 101 (1986) 515-523
11. Friedman D.S., Quigley H.A., Gelb L., et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci 48 (2007) 5052-5057
12. Robin A.L., Novack G.D., Covert D.W., Crockett R.S., and Marcic T.S. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol 144 (2007) 533-540
13. Friedman D.S., Hahn S.R., Gelb L., et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology 115 (2008) 1320-1327
14. McDonald H.P., Garg A.X., and Haynes R.B. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 288 (2002) 2868-2879